 |
|
Painful condition affecting kidney failure patients increases risk of death
September 28, 2007Mass General study supports association of newly reported disorder with imaging contrast agent
A painful and debilitating condition that affects patients with kidney failure may be more common than previously believed and appears to be strongly associated with prior exposure to certain contrast agents used in imaging studies. In addition, individuals with this syndrome - called nephrogenic systemic fibrosis (NSF) - appear to have a significantly increased risk of dying. The findings from Massachusetts General Hospital (MGH) investigators appear in the October issue of the journal Arthritis & Rheumatism.
"Our analysis found that hemodialysis patients who had undergone imaging studies using a gadolinium-containing contrast agent have more than 10 times the risk of developing NSF as do patients with no prior exposure to gadolinium," says Jonathan Kay, MD, director of the Rheumatology Clinical Research Unit at MGH, the report's senior author. "Among those with NSF, the risk of dying within two years was three to five times greater than for patients without the condition from the same dialysis centers."
The primary symptoms of NSF are rapid and progressive thickening, hardening and darkening of the skin, primarily on the arms and legs. Originally believed to affect only the skin, the condition now is known to involve internal organs. NSF can be extremely painful, causing the skin to contract to the point where movement is difficult or impossible. The condition has been reported only during the past 10 years and only among patients with abnormal kidney function, primarily those with advanced kidney disease. In 2006, an Austrian physician noted that NSF developed in several of his dialysis patients who had undergone MR imaging studies using gadolinium-containing contrast.
Reports of NSF in the medical literature have discussed only small numbers of cases and have not included comparative information from patients shown to not have the disorder. To better assess the prevalence of NSF among patients with advanced kidney disease and to examine a potential association with gadolinium-containing contrast agents, the team led by Derrick J. Todd, MD, PhD, now a rheumatology fellow at the Brigham & Women's Hospital, enrolled hemodialysis patients treated at six outpatient centers in the Boston area.
The investigators devised a simple examination to check for the three skin features of NSF - tightening, thickening and darkening - and also collected demographic information. Available electronic medical records for participants were analyzed for any history of imaging studies, predominantly MRI examinations, using gadolinium-containing contrast.
Among 186 study participants, 25 (13 percent) were determined to have NSF based on the presence of at least two of the three skin findings. Examination of skin biopsy samples from five study participants supported the examination-based diagnosis of NSF in each. Electronic medical records were available for 90 participants; 17 of those had a skin examination consistent with NSF, all but one with documented prior exposure to gadolinium. The investigators were particularly surprised to find that 48 percent of participants with skin changes of NSF died within two years of their examination. Among participants without NSF, the death rate was 20 percent, which would be expected among patients with advanced kidney failure undergoing long-term hemodialysis treatment.
"Our study demonstrates a definite and very strong association between exposure to gadolinium-containing contrast and the subsequent development of NSF," says Kay, an associate clinical professor of Medicine at Harvard Medical School. "We need to address the mechanism by which this devastating disease occurs and develop effective treatment and preventive strategies, so that gadolinium-containing contrast agents - which provide important clinical information - can be used safely in patients with kidney failure."
At this time, Kay notes, patients scheduled to undergo such imaging studies should first have their kidney function checked, and gadolinium-containing contrast should not be used in those with significant underlying kidney disease. More information is needed to determine the risk for those with milder forms of kidney disease. The study was conducted by Todd and co-author Anna Kagan, MD, PhD, while they were medical residents at MGH. Lori B. Chibnik of Brigham and Women's Hospital was the study's biostatician.
Massachusetts General Hospital
The primary symptoms of NSF are rapid and progressive thickening, hardening and darkening of the skin, primarily on the arms and legs. Originally believed to affect only the skin, the condition now is known to involve internal organs. NSF can be extremely painful, causing the skin to contract to the point where movement is difficult or impossible. The condition has been reported only during the past 10 years and only among patients with abnormal kidney function, primarily those with advanced kidney disease. In 2006, an Austrian physician noted that NSF developed in several of his dialysis patients who had undergone MR imaging studies using gadolinium-containing contrast.
Reports of NSF in the medical literature have discussed only small numbers of cases and have not included comparative information from patients shown to not have the disorder. To better assess the prevalence of NSF among patients with advanced kidney disease and to examine a potential association with gadolinium-containing contrast agents, the team led by Derrick J. Todd, MD, PhD, now a rheumatology fellow at the Brigham & Women's Hospital, enrolled hemodialysis patients treated at six outpatient centers in the Boston area.
The investigators devised a simple examination to check for the three skin features of NSF - tightening, thickening and darkening - and also collected demographic information. Available electronic medical records for participants were analyzed for any history of imaging studies, predominantly MRI examinations, using gadolinium-containing contrast.
Among 186 study participants, 25 (13 percent) were determined to have NSF based on the presence of at least two of the three skin findings. Examination of skin biopsy samples from five study participants supported the examination-based diagnosis of NSF in each. Electronic medical records were available for 90 participants; 17 of those had a skin examination consistent with NSF, all but one with documented prior exposure to gadolinium. The investigators were particularly surprised to find that 48 percent of participants with skin changes of NSF died within two years of their examination. Among participants without NSF, the death rate was 20 percent, which would be expected among patients with advanced kidney failure undergoing long-term hemodialysis treatment.
"Our study demonstrates a definite and very strong association between exposure to gadolinium-containing contrast and the subsequent development of NSF," says Kay, an associate clinical professor of Medicine at Harvard Medical School. "We need to address the mechanism by which this devastating disease occurs and develop effective treatment and preventive strategies, so that gadolinium-containing contrast agents - which provide important clinical information - can be used safely in patients with kidney failure."
At this time, Kay notes, patients scheduled to undergo such imaging studies should first have their kidney function checked, and gadolinium-containing contrast should not be used in those with significant underlying kidney disease. More information is needed to determine the risk for those with milder forms of kidney disease. The study was conducted by Todd and co-author Anna Kagan, MD, PhD, while they were medical residents at MGH. Lori B. Chibnik of Brigham and Women's Hospital was the study's biostatician.
Massachusetts General Hospital
Kidney Failure Current Events and Kidney Failure News RSSPreventing anemia is important to kidney disease patients' quality of life
Maintaining sufficient red blood cell levels is important to the physical and mental health of patients with chronic kidney disease (CKD), according to a study appearing in the January 2009 issue of the Clinical Journal of the American Society Nephrology (CJASN). The findings indicate that preventing anemia in kidney disease patients should be an integral part of their care.
African-American Canadians who receive kidney transplants fare better than those in US
African American kidney disease patients in both Canada and the United States are less likely than Caucasian Americans to have access to kidney transplants, but only African-Americans in the United States have worse health outcomes than Caucasians after a transplant is performed.
Scientists identify cell changes leading to impaired 'artificial kidney' function
Molecular targets identified by a Spanish research team may hold the key to freedom for some sufferers of kidney disease. A new study published in Disease Models & Mechanisms (DMM), dmm.biologists.org, reveals the cellular signals which cause one treatment for kidney failure to lose its usefulness over time.
Researchers propose new ultrasound screening criteria for diagnosing polycystic kidney disease
Modification of the current screening criteria are needed for diagnosing patients with autosomal dominant polycystic disease (ADPKD), according to a study appearing in the January 2009 issue of the Journal of the American Society Nephrology (JASN). The results suggest that some patients with a milder form of the disease may otherwise be misdiagnosed.
Hypertension disparity linked to environment
Social environment may play a greater role in the disparity between the numbers of African Americans living with hypertension compared to non-Hispanic whites with the disease.
Larger labs report kidney function routinely
Labs that conduct the highest number of routine blood tests are more likely than others to report estimated glomerular filtration rate (eGFR), an important measure of kidney function that can identify early kidney disease.
Late-breaking results of clinical trial on therapeutic endovascular cooling reported at TCT 2008
Late-breaking results from the COOL RCN (COOLing to Prevent Radio Contrast Nephropathy in Patients Undergoing Diagnostic or Interventional Catheterization) Trial were presented during the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).
New gene variant identified for nondiabetic end stage renal disease in African-Americans
Scientists at Johns Hopkins schools of Public Health and Medicine have, for the first time, identified variants in the gene MYH9 that are associated with increased risk for non-diabetic end stage renal disease (ESRD,) which is the near-loss of kidney function leading to either dialysis of transplant. MYH9, located on the 22 chromosome, is the first gene identified for common forms of kidney disease.
Newly found gene variants account for kidney diseases among African-Americans
For the first time, researchers have identified variations in a single gene that are strongly associated with kidney diseases disproportionately affecting African-Americans. This work was conducted by researchers at the National Institutes of Health (NIH) and by NIH-funded investigators at the Johns Hopkins University.
Battling Diabetes with Beta Cells
Affecting eight percent of America's population, diabetes can lead to blindness, kidney failure, strokes and heart disease. Thanks to Tel Aviv University researchers, a new cure -- based on advances in cell therapy -- may be within reach.
More Kidney Failure Current Events and Kidney Failure News Articles
 | Caring for a Cat with Kidney Failure by Sarah Caney 'Caring for a cat with kidney failure' has been written as an information source and support tool primarily aimed at cat owners whose cats have been diagnosed with kidney failure. It is also designed to be a resource for student vets, veterinary nurses and technicians. The science and emotional aspects of dealing with a diagnosis of kidney failure are addressed. The book explains what a diagnosis... |
 | Kidney Failure Explained (Class Health) by Andy Stein, Janet Wild 30,000 people in the UK today are on treatment for chronic kidney failure. But up until now there hasn't been a complete reference manual that tells people everything they need to know about their condition. Kidney Failure Explained answers all the questions that people with a kidney condition want to ask, including those questions that they may be embarrassed about asking their GP. It also shows... |
 | Kidney Failure: the Facts by J. Stewart Cameron Guy's and St Thomas' Hospitals, U.K. Practical patient-education text on kidney disease, for patients and their families. Explains in laylanguage the causes and symptoms of kidney failure and the options available for treatment, including dialysis and transplantation.... |
 | Living Well with Kidney Failure: A Guide to Living Your Life to the Full (Class Health) by Juliet Auer This practical and inspiring book will give you the confidence to live a full and rewarding life. It highlights the experiences of a number of very different people, from all walks of life, ages and family situations. These shared personal accounts celebrate the fullness of life that people living with kidney failure can, and do,... |
| Kidney Failure and the Federal Government by Committee for the Study of the Medicare End-Stage Renal Disease Program, Division of Health Care Services Since 1972, many victims of endstage renal disease (ESRD) have received treatment under a unique Medicare entitlement. This book presents a comprehensive analysis of the federal ESRD program: who uses it, how well it functions, and what improvements are needed.The book includes recommendations on patient eligibility, reimbursement, quality assessment, medical ethics, and research needs.Kidney... | |
 | Beyond The Barriers: Learning To Live with Kidney Failure by Alvieno Stinson |
 | Strength and Compassion in Kidney Failure - Writings of Mildred (Barry) Friedman by E.A. Friedman, Eli A. Friedman State Univ. of New York, Brooklyn. A collection of medical columns, short stories, and letters written by the late 'Barry' Friedman. This text is to honor her for her efforts on behalf of kidney patients, and to give comfort to those going through kidney transplant, renal failure, diabetes, and Addison's disease. For general readers. Softcover, hardcover listed week... |
 | Eating Well with Kidney Failure by Helena Jackson |
 | Kidney Transplantation: Principles and Practice by Peter Morris, Stuart J. Knechtle Updated to reflect today's practice guidelines, the new edition of this comprehensive text remains the definitive resource on all aspects of renal transplantation, including immunological, pathological, psychological and ethical considerations. It examines evaluation, management, and procurement of living and deceased donor kidneys, the selection of suitable recipients, interpretation of graft... |
 | The Official Patient's Sourcebook on Kidney Failure: A Directory for the Internet Age by Icon Health Publications |
| © 2009 BrightSurf.com |